Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it remains still orphan of an adequate therapeutic …

CYP2E1 is one of the fifty-seven cytochrome P450 genes in the human genome and is
highly conserved. CYP2E1 is a unique P450 enzyme because its heme iron is constitutively …

Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it remains still orphan of an adequate therapeutic …

Proper dietary habits are a vital element of cardiovascular (CV) treatment, and-according to
the current guidelines-a diet rich in antioxidants is generally recommended. It remains …

The metabolic-associated fatty liver disease (MAFLD) is a condition of fat accumulation in
the liver in combination with metabolic dysfunction in the form of overweight or obesity and …

Background Metabolic associated fatty liver disease (MAFLD) is a novel terminology
introduced in 2020 to provide a more accurate description of fatty liver disease associated …

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) emerged as the most prevalent liver
disorder contributing significantly to disease burden worldwide. It manifests as a broad …

The role of food constituents as pharmacological agents is an important consideration in
health and obesity. Vitamin C acts as a small molecule antioxidant but is also a co-factor for …

Background: Vitamins and carotenoids may be involved in the pathogenesis of non-
alcoholic fatty liver disease (NAFLD). Previously related publications mainly focused on …

Abstract Non-alcoholic steatohepatitis (NASH), a severe form of non-alcoholic fatty liver
disease (NAFLD), can progress to cirrhosis, hepatocellular carcinoma (HCC), and hepatic …